Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows Revision: v3.6.6, indicating a new revision of the study record was posted, replacing the previous v3.6.5.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study history's revision label was updated from v3.6.4 to v3.6.5, indicating a new platform revision for the page.SummaryDifference0.1%

- Check37 days agoChange DetectedOn 2026-07-21, the page adds new sections for Study Status and Study Identification and updates the revision to v3.6.4. The earlier v3.6.3 revision was removed on 2026-07-10.SummaryDifference0.5%

- Check52 days agoChange DetectedNew sections for Study Status and Study Identification were added to the study history on 2026-07-10 and 2026-07-08, representing updates to the trial’s current status and identifying details; a deletion was recorded on 2026-06-29.SummaryDifference0.4%

- Check59 days agoChange DetectedThis update adds several core study sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Sponsor/Collaborators, Study Status) and introduces Revision: v3.6.3 (version 14) to the record, reflecting expanded study detail.SummaryDifference1.0%

- Check66 days agoChange DetectedThe record history now shows a new revision tag (v3.6.2), replacing the previous v3.6.0, indicating the study record has been updated.SummaryDifference0.1%

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.